Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.
about
Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.Drugging sphingosine kinases.A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties.A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma.The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.Glycosphingolipids and cell death: one aim, many waysEffect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertensionResveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.3-Ketosphinganine provokes the accumulation of dihydroshingolipids and induces autophagy in cancer cells.Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs.Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells.Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents.Modulation of sphingosine 1-phosphate (S1P) attenuates spatial learning and memory impairments in the valproic acid rat model of autism.From the configurational preference of dihydroceramide desaturase-1 towards Δ6-unsaturated substrates to the discovery of a new inhibitor.Ovarian Function Modulates the Effects of Long-Chain Polyunsaturated Fatty Acids on the Mouse Cerebral Cortex.
P2860
Q30252641-37396EF0-C1DC-42FA-A006-8A64430EC7EBQ30366282-478E8AB6-96CC-4074-97B8-9F3AE50652E2Q35580940-7F5C11E2-C1C2-4544-B17A-6F07D859AB84Q35774799-981B3858-6863-4F4B-AC4F-C2D21657B497Q36359489-4EA8A246-69A1-491D-968D-7B6C1EC721B5Q36405917-08AD2E62-289B-4B43-AC73-C90802BCFE15Q37020344-BF4E5544-E896-4888-94B4-0E8A6B7053DFQ38262594-5D0C40CA-1E64-4FF8-9186-09633198E830Q38790022-16281059-3A52-4AD9-94C7-DB773EBC3F6CQ38890587-CBA72A0B-21D9-4E7E-A3F1-8ABADE553118Q38915115-19B163BB-C2D8-466C-9265-E16660FCAF6DQ42119999-5032C7A0-A08C-470D-B8E8-FE639FFE58C8Q42972395-723D9434-374F-413A-BDA7-69E8AA7C8825Q47146575-233FFF49-0BED-4FD3-B8DC-49D6699EA5CFQ47316938-5A9C44DD-DE38-4E73-9216-610C4B51D609Q53377847-AFDFB112-AE35-42E5-9086-D49D79FDB9CBQ55023415-D2FCCE8D-DAFC-40A0-BBB8-DDA5E5C406C3
P2860
Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Inhibition of dihydroceramide ...... osine kinase inhibitor SKI II.
@en
type
label
Inhibition of dihydroceramide ...... osine kinase inhibitor SKI II.
@en
prefLabel
Inhibition of dihydroceramide ...... osine kinase inhibitor SKI II.
@en
P2093
P2860
P356
P1476
Inhibition of dihydroceramide ...... osine kinase inhibitor SKI II.
@en
P2093
Francesca Cingolani
Josefina Casas
Mireia Casasampere
Pol Sanllehí
P2860
P304
P356
10.1194/JLR.M049759
P577
2014-05-29T00:00:00Z